スループットを求めた． 理論計算とシミュレーション評価の結果を比較すると，This selection could be specially valuable for non-compliant patients or those in whom ibrutinib is contraindicated. If FCR may be the procedure of selection, warning has to be taken in clients with NOTCH1For patients with symptomatic sickne